⌘K

10:28:22·1386d

13D/GFilingvia Quantisnow

SEC Form SC 13G/A filed by Elevation Oncology Inc. (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.

ELEV· Elevation Oncology Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

ELEV
Elevation Oncology Inc.
Health Care

Recent analyst ratings

Mar 24UpdateStephens$1.00
Mar 21UpdateLeerink Partners$1.00
Mar 21UpdateCitizens JMP-
Mar 21UpdatePiper Sandler$0.70
Jan 3UpdateWilliam Blair-
May 31UpdatePiper Sandler$10.00

Related

SEC266d
SEC Form 15-12G filed by Elevation Oncology Inc.
SEC272d
SEC Form EFFECT filed by Elevation Oncology Inc.
SEC272d
SEC Form EFFECT filed by Elevation Oncology Inc.
SEC273d
Amendment: SEC Form SCHEDULE 13D/A filed by Elevation Oncology Inc.
INSIDER277d
SEC Form 4 filed by Director Sandler Alan B.
INSIDER277d
SEC Form 4 filed by Director Mootz Darcy
INSIDER277d
SEC Form 4 filed by Director Elms Steve
INSIDER277d
SEC Form 4 filed by Director Clackson Timothy P